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Abstract 
The breakpoints of type-1 NF1 deletions encompassing 1.4-Mb are located within NF1-REPa and 
NF1-REPc, which exhibit a complex structure comprising different segmental duplications in 
direct and inverted orientation. Here, we systematically assessed the proportion of type-1 NF1 
deletions caused by nonallelic homologous recombination (NAHR) and those mediated by other 
mutational mechanisms. To this end, we analysed 236 unselected type-1 NF1 deletions and 
observed that 179 of them (75.8%) had breakpoints located within the NAHR hotspot PRS2 
whereas 39 deletions (16.5%) had breakpoints located within PRS1. Sixteen deletions exhibited 
breakpoints located outside of these NAHR hotspots but were also mediated by NAHR. Taken 
together, the breakpoints of 234 (99.2%) of the 236 type-1 NF1 deletions were mediated by 
NAHR. Thus, NF1-REPa and NF1-REPc are strongly predisposed to recurrent NAHR, the main 
mechanism underlying type-1 NF1 deletions. We also observed a non-random overlap between 
type-1 NF1 deletion breakpoints and G-quadruplex-forming sequences (GQs) as well as regions 
flanking PRDM9A-binding sites. These findings imply that GQs and PRDM9A binding-sites 
contribute to the clustering of type-1 deletion breakpoints. The co-location of both types of 
sequence was at its highest within PRS2, indicative of their synergistic contribution to the greatly 
increased NAHR activity within this hotspot.  
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Introduction 
Large NF1 deletions (also termed NF1 microdeletions) cause the chromosome 17q11.2 deletion 
syndrome (MIM# 613675) which is characterized by a severe manifestation of neurofibromatosis 
type 1 (MIM# 162200) (Mautner et al., 2010; reviewed by Kehrer-Sawatzki et al., 2017). 
Different types of NF1 microdeletion have been identified (type 1, 2 and 3 or atypical) which are 
distinguishable by the size and location of the breakpoints and their underlying mutational 
mechanisms (Kehrer-Sawatzki et al., 2004; Steinmann et al., 2007; Bengesser et al., 2010; 
Pasmant et al., 2010; Roehl et al., 2010; Messiaen et al., 2011; Vogt et al., 2012, 2014; Zickler et 
al., 2012). Most common are the type-1 NF1 deletions which have breakpoints located within the 
low-copy repeats NF1-REPa and NF1-REPc (Dorschner et al., 2000; Jenne et al., 2001; López-
Correa et al., 2001; Forbes et al., 2004). Multiplex ligation-dependent probe amplification 
(MLPA) and commercially available arrays have been deployed to identify NF1 microdeletions. 
However, these techniques are insufficiently precise to determine the exact location of the 
deletion breakpoints and consequently, the molecular mechanism causing the deletions. Only 
breakpoint-spanning PCRs, and the subsequent sequence analysis of the breakpoint-spanning 
PCR products, potentiate the identification of the breakpoints at the highest level of resolution 
and hence the identification of the underlying mutational mechanisms. Previously performed 
studies have suggested that most type-1 NF1 deletions are mediated by nonallelic homologous 
recombination (NAHR) within the PRS1 and PRS2 hotspots (De Raedt et al., 2006; Messiaen et 
al., 2011; Bengesser et al., 2014; Hillmer et al., 2016, 2017). However, as yet, no systematic 
analysis of an unselected cohort of type-1 NF1 deletions has been performed in order to 
determine the proportion of those deletions which exhibit breakpoints that are located outside of 
the known NAHR hotspots PRS1 and PRS2. Further, it remains unclear what proportion of type-
1 NF1 deletions are not mediated by NAHR but originate instead by another mutational 
mechanism.  
In the study presented here, we analysed a total of 236 type-1 NF1 deletions in order to address 
these open questions. These deletions were initially identified by MLPA and represent the largest 
cohort of type-1 NF1 deletions analysed to date. We determined the location of the deletion 
breakpoints at the highest possible resolution by means of a combination of long-range paralog-
specific PCRs, array analysis and breakpoint-spanning PCRs. Our findings demonstrate 
unequivocally that NAHR is indeed the mechanism underlying the vast majority of type-1 NF1 
deletions. NF1 microdeletions initially considered to be of type-1 according to MLPA, but which 
turn out to be caused by mutational mechanisms other than NAHR, are very rare. Thus, only two 
of the 236 deletions analysed were found not to be mediated by NAHR. Further, we observed 
pronounced clustering of NAHR-mediated breakpoints, a finding which we believe is likely to be 
causally determined by synergy between G-quadruplex forming sequences and PRDM9A binding 
sites. 
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Materials and Methods  
Patients  
In this study, we analysed genomic DNA derived from the blood of 152 NF1 patients with type-1 
NF1 deletions, which were initially identified by MLPA (P122 NF1 area probemix, version C2, 
MRC Holland, The Netherlands). The deletion breakpoints of these 152 patients have not 
previously been published. Here, we determined the precise position of the breakpoints of these 
152 type-1 NF1 deletions at the highest possible resolution. Subsequently, we combined these 
data with the breakpoint location of 84 type-1 NF1 deletions characterized in our previous studies 
(Jenne et al., 2001; Mautner et al., 2010; Hillmer et al., 2016, 2017). In total, we evaluated the 
breakpoint locations of 236 type-1 NF1 deletions originally identified by different centres as 
summarized in Supp. Table S1. The patients provided written informed consent and the study 
was approved by the respective institutional review boards. 
Breakpoint-spanning PCRs (BS-PCRs) 
BS-PCRs were performed by means of the Expand™ Long Range dNTPack (Merck, Darmstadt, 
Germany) with primers listed in Supp. Tables S2-4 and 400 ng genomic blood-derived DNA 
from the patients as template. The genomic locations of the BS-PCR products pertaining to the 
NAHR hotspots PRS1 and PRS2 are schematically indicated in Supp. Figure S1. The PCR 
products were analysed by Sanger sequencing using the primers listed in Supp. Table S5 and the 
BigDye™ Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Schwerte, 
Germany) on an ABI 3130xl genetic analyzer (Applied Biosystems, Waltham, Massachusetts, 
USA). 
Breakpoint identification 
The assignment of the deletion breakpoints, represented as NAHR-associated strand exchange 
regions (SERs), involved the sequence analysis of breakpoint-spanning PCR products (BSPs) 
amplified from blood-derived DNA samples from the patients. The sequences of the BSPs were 
compared with the reference sequences of NF1-REPa and NF1-REPc according to human 
genome assembly 19 (GRCh 37; hg19). In order to distinguish between NF1-REPa and NF1-
REPc derived sequences within the BSPs, we considered only those sequence differences 
between the BSPs and the reference sequence that occurred at sites of (i) paralogous sequence 
variants (PSVs), which are non-polymorphic sequence differences between NF1-REPa and NF1-
REPc, and (ii) rare single nucleotide variants (SNVs) with a minor allele frequency (MAF) ≤ 1% 
as described in our previous study (Hillmer et al., 2017).  
Paralog-specific PCRs  
These long-range PCRs were performed with a paralog-specific primer annealing either to NF1-
REPa or NF1-REPc. The primers used for these PCRs are listed in Supp. Table S6 alongside the 
annealing temperatures that allowed for paralog-specific PCR assays. Sequence analysis of the 
PCR products indicated the copy-number of the amplified regions by evaluating homozygosity or 
heterozygosity at the sites of SNVs.  
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Array analysis 
Custom-designed array CGH was performed using an 8x15K array (Agilent SurePrint G3 human 
CGH microarray) in order to improve the breakpoint prediction of type-1 NF1 deletions 
exhibiting breakpoints located within the region of high sequence homology between NF1-REPa 
and NF1-REPc (genomic regions R2 and R4; Supp. Table S7 and Figure S2). Commercially 
available high-resolution arrays include only a very limited number of array probes located 
within the regions of high sequence homology between NF1-REPa and NF1-REPc. By contrast, 
our custom-designed array comprises 90 oligonucleotide probes suitable for copy number 
evaluation located within these regions. The oligonucleotides were designed using the 
SureDesign platform (https://earray.chem.agilent.com/suredesign/) and encompass several 
paralogous sequence variants (PSVs) and SNVs with a MAF ≤ 1% that distinguish between NF1-
REPa and NF1-REPc. Printing of the arrays, hybridization, normalization, processing of the raw 
data and quality control were performed by IMGM Laboratories (Martinsried, Germany). The 
deletion in patient R003150/2 was also characterized by means of CytoScan™ HD array analysis 
(Affymetrix). 
Identification of G-quadruplex forming repeats 
We screened the 51-kb region of high sequence homology between NF1-REPa and NF1-REPc, 
located in direct orientation to each other, for the presence of the G-quadruplex forming 
consensus sequence, (G≥3N1-7 G≥3N1-7 G≥3N1-7 G≥3) (Huppert and Balasubramanian, 2005) using 
the programs QuadBase2 (http://quadbase.igib.res.in/TetraPlexFinder) (configuration: medium 
stringency) (Dhapola and Chowdhury, 2016) and the non-B DNA database (https://nonb-
abcc.ncifcrf.gov/apps/nBMST/default/) (Cer et al., 2013). The 51-kb region investigated ranged 
from nucleotide position 28,948,896 to 28,999,883 in NF1-REPa and from 30,364,989 to 
30,415,983 in NF1-REPc according to hg19.  
Using these analytical tools, we also screened the 24-kb spanning CMT1A-REPs at 17p12 for the 
presence of G-quadruplex forming sequences. The chromosome 17 regions investigated ranged 
from nucleotide positions 14,074,029 to 14,098,042 and 15,470,903 to 15,494,902. NAHR 
between the CMT1A-REPs causes 1.4-Mb deletions associated with hereditary neuropathy with 
liability to pressure palsies (HNPP; MIM# 162500) and the reciprocal duplications causing 
Charcot-Marie Tooth disease type-1 (CMT1A; MIM# 118220) (Chance et al., 1994; Lopes et al., 
1998). The HNPP-associated deletion breakpoints representing the strand exchange regions 
(SERs) of these NAHR-mediated rearrangements have been precisely determined by Turner et al. 
(2008) and were evaluated by us in order to assess the overlap between SERs and G-quadruplex 
forming sequences as well as PRDM9A variant binding-sites as described in the following 
paragraph. 
PRDM9A binding-site datasets  
The most common variant of the human PRDM9 protein, termed PRDM9A, binds to the 
consensus sequence 5′-CCNCCNTNNCCNC-3′ which is enriched in ∼40% of recombination 
hotspots (Myers et al., 2008; Baudat et al., 2010). It has been shown that PRDM9A also 
recognizes variants of this consensus motif with the sequence 5'-CCNCCNCNNCCNC-3' and 5'-
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CCNCCNCNNCANC-3' (Patel et al., 2016). We searched the 51-kb region of high sequence 
homology between NF1-REPa and NF1-REPc for the presence of all three predicted PRDM9A 
binding motifs by means of the software tool "Find Individual Motif Occurrences (FIMO)" 
(Grant et al., 2011). Next, we determined 250-bp windows flanking the PRDM9A binding-sites to 
create the PRDM9A binding-site dataset. We selected this window-size since this is the size-range 
of the nucleosome-depleted regions mediated by PRDM9 as determined by Baker et al. (2014) 
who analysed the hotspots of allelic homologous recombination in the mouse. Upon PRDM9 
binding, it locally trimethylates histone H3 at lysine 4 and the nucleosomes methylated by 
PRDM9 become laterally displaced thereby creating a nucleosome-depleted region (Baker et al. 
2014). The recombination-initiating DNA double-strand break (DSB) is then induced by the 
topoisomerase SPO11 within the nucleosome-depleted region followed by the reciprocal 
exchange of DNA between chromatids, forming Holliday junctions according to the DNA 
double-strand break (DSB) repair model involving a double Holliday junction (dHj) (model 
shown in Supp. Figure S3).  
A comparable analysis was performed to create a PRDM9A binding-site dataset for the regions of 
high sequence homology between the CMT1A REPs. 
Simulation analysis  
Simulation analysis was performed by means of the software Statistical Analysis System (SAS). 
Each simulation analysis included 2000 independent investigation steps (iterations) performed to 
assess the overlap defined as a minimum of 1-bp between randomly chosen strand exchange 
regions (SERs) with G-quadruplex forming sequences (GQs) or between SERs and the PRDM9A 
binding-site dataset. By means of these simulations, we tested the null hypothesis that the 
observed overlap of the SERs with GQs and SERs with the PRDM9A binding-site dataset was no 
greater than would be expected by chance alone (Supp. Text S1).  
 
Results 
Breakpoint identification of type-1 NF1 deletions 
In the study presented here, we analysed the largest cohort of type-1 NF1 deletions reported to 
date. This cohort includes 236 type-1 NF1 deletions identified in unrelated patients at different 
centres (Supp. Table S1). The breakpoints of 84 of these 236 deletions have been characterized in 
our previous studies by means of four classical breakpoint-spanning PCRs (BS-PCRs) designed 
to detect breakpoints located within the NAHR hotspots PRS1 and PRS2 (Jenne et al., 2001; 
López-Correa et al., 2001; Mautner et al., 2010; Hillmer et al. 2016, 2017). In order to identify 
the breakpoints of the 152 additional type-1 NF1 deletions in this cohort, we also performed these 
classical BS-PCRs with primers listed in Supp. Table S2. However, only 117 of these 152 type-1 
NF1 deletions were positive for these classical BS-PCRs whereas the breakpoints of 35 deletions 
could not be identified by these means (Figure 1). To identify the breakpoints of these 35 
deletions, we performed additional BS-PCRs with primers located between PRS1 and PRS2 
(Supp. Figure S1, Table S3). Additionally, we performed custom-designed CGH array analysis 
with a high density of probes located within the regions of high sequence similarity between 
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NF1-REPa and NF1-REPc (Supp. Table S7 and Figure S2). To verify the array results, we 
applied paralog-specific long-range PCRs. Sequence analysis of the paralog-specific PCR 
products indicated their copy number by evaluation of homozygosity or heterozygosity of SNVs. 
By means of these methods, the breakpoints of 33 of the 35 type-1 deletions could be identified 
(Figure 1; Supp. Table S8).  
Surprisingly, 12 of the 33 deletions turned out to exhibit breakpoints that were located within 
PRS1 and PRS2, even though they had not been positive for the classical BS-PCRs as previously 
performed (Hillmer et al., 2017). However, by means of optimized PCR conditions or different 
primer sets used for the BS-PCRs, positive breakpoint-spanning PCR products (BSPs) were 
successfully obtained (Supp. Text S2 and Table S4). We noted that the breakpoints of four of 
these 12 deletions were located within PRS1 and the remaining eight had breakpoints located 
within PRS2 (Supp. Table S8). The breakpoints of two of these PRS2-mediated deletions, those 
of patients SB94 and R131070/18, could not be amplified with the primers used for the classical 
BS-PCRs because of the presence of rare sequence variants at the primer binding site of primer 
2290for. However, optimized primer sets were established that allowed for the amplification of 
positive BSPs in these cases (Supp. Text S2 and Table S4). Sequence analysis of these products 
indicated that these two patients (SB94 and R131070/18) exhibited high sequence diversity 
within PRS2, as determined by comparison of the BSP sequence with the human reference 
sequence. Both patients had a rare PRS2 haplotype that was also detected in three other 
individuals by means of the analysis of the wild-type sequence of PRS2 (Supp. Figure S4). The 
high sequence diversity of this haplotype compared with the reference sequence probably 
resulted from numerous historical gene conversion events between NF1-REPa and NF1-REPc.  
We also identified five deletions with breakpoints located centromeric to the proximal boundary 
of PRS2 as previously defined (Supp. Table S9 and Figure S1). Owing to the close proximity of 
the deletion breakpoints to PRS2, these five deletions were considered to be PRS2-mediated and 
the extent of PRS2 had to be corrected accordingly (Supp. Figures S1 and S5). Breakpoint-
spanning PCR products were amplified from DNA of these five patients by means of newly 
established primer sets (listed in Supp. Table S4). 
Among the 33 type-1 deletions, we identified 13 deletions with breakpoints located in the region 
between PRS1 and PRS2, a 13,858-bp region exhibiting high sequence similarity between NF1-
REPa and NF1-REPc (Supp. Figure S1, Figures 1 and 2C). These 13 deletions were also 
mediated by NAHR as determined by sequence analysis of the breakpoint-spanning PCR 
products. Remarkably, eight of these 13 deletions had breakpoints located within a 476-bp region 
between PRS1 and PRS2. In total, eight (3.4%) of the 236 deletions exhibited breakpoints within 
this 476-bp region. Three NAHR-mediated type-1 deletions were identified which had 
breakpoints located centromeric to PRS1 but still within the region of high-sequence homology 
between NF1-REPa and NF1-REPc (Supp. Tables S8 and S10, Figures 1 and 2). 
Of the 236 NF1 deletions analysed, only two (0.8%) were not mediated by NAHR [R003150/2 
and R282241/39]. This conclusion was based upon the positions of the deletion breakpoints as 
determined by paralog-specific PCRs and array analysis. The proximal deletion breakpoint of 
patient R003150/2 was found to be located within the SMURF2-P pseudogene of NF1-REPa 
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whereas the distal deletion breakpoint was identified within the LRRC37B gene of NF1-REPc 
(Supp. Figure S6). In patient R282241/39, the proximal deletion breakpoint was located telomeric 
to PRS2 within NF1-REPa whereas the distal deletion breakpoint within NF1-REPc was located 
centromeric to PRS1 (Supp. Figure S7 and Table S11). Even though we were unable to narrow 
down the deletion breakpoints any further by means of breakpoint-spanning PCRs, our findings 
clearly indicated that the breakpoints were not located within those regions exhibiting high 
sequence similarity between NF1-REPa and NF1-REPc. Since high sequence homology within 
extended genomic regions is a prerequisite for NAHR to occur, we conclude that these deletions 
were not mediated by NAHR.  
Taken together, the analysis of the 236 NF1 deletions indicated that 179 (75.8%) had breakpoints 
located within the NAHR hotspot PRS2, and 39 (16.5%) within PRS1 (Figure 1). Only 18 (7.6%) 
of the 236 deletions exhibited breakpoints that were not located within the known NAHR 
hotspots PRS1 and PRS2. Remarkably, 16 of these 18 deletions were also caused by NAHR. 
Taken together, 234 (99.2%) of the 236 type-1 deletion breakpoints investigated were found to 
have been mediated by NAHR which therefore constitutes the main mutational mechanism 
underlying type-1 NF1 deletions. 
G-quadruplex forming sequences overlap with SERs of type-1 NF1 deletions 
G-quadruplex forming sequences (GQs) have been reported to be enriched in genomic regions 
flanking the breakpoints of non-recurrent CNVs in humans (Bose et al., 2014). Here, we 
investigated whether GQs and the breakpoints of type-1 NF1 deletions would coincide more 
often than might be expected assuming a random distribution of both sequences within the 51-kb 
region of high sequence homology between NF1-REPa and NF1-REPc. The breakpoints of type-
1 NF1 deletions are represented as strand exchange regions (SERs) between NF1-REPa and NF1-
REPc. The SERs indicate the locations of double Holliday junction (dHj) resolution (Supp. 
Figure S3) and exhibit 100% sequence homology between NF1-REPa and NF1-REPc. The SERs 
are flanked by paralogous sequence variants (PSVs) which serve to distinguish NF1-REPa from 
NF1-REPc. In total, we analysed 129 SERs, encompassing 23-bp up to 670-bp, located within a 
51-kb stretch of direct sequence homology between NF1-REPa and NF1-REPc (Supp. Table 
S12). Within this 51-kb region, 21 GQs were identified, ranging in length from 15-bp to 39-bp 
(Supp. Table S13). An overlap of at least 1-bp between the 21 GQs and the 129 SERs of type-1 
NF1 deletions was observed in a total of 64 cases. In order to investigate whether this overlap 
could have occurred by chance alone (null hypothesis), we performed a simulation analysis. The 
simulations included 2000 investigation steps (iterations). In each step, the number of overlaps 
between 129 randomly chosen SERs located within the 51-kb region of high sequence homology 
between NF1-REPa and NF1-REPc and the 21 GQs was determined. However, in none of these 
simulations did the number of overlaps between SERs and GQs exceed the observed number of 
overlaps (N= 64). These simulations therefore indicated that the null hypothesis had to be 
rejected (empirical p < 0.00001; Supp. Text S1). Consequently, the overlap between the observed 
SERs and the 21 GQs may be interpreted as being non-random and likely to be causally 
determined (Supp. Figure S8; Figure 3).  
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PRDM9A binding-sites and SERs of type-1 NF1 deletions 
By means of simulation analysis, we also investigated whether a non-random overlap might exist 
between the 129 SERs of type-1 NF1 deletions and 250-bp regions [HILDE: Do you mean 
250bp or 125bp? Correct also in Suppl. Figure legends] flanking 26 predicted PRDM9A 
binding-sites (PRDM9A binding-site dataset) located within the 51-kb region of high sequence 
homology between NF1-REPa and NF1-REPc (Supp. Table S14). According to these 
simulations, the null hypothesis, namely that the overlap between the SERs of type-1 NF1 
deletions and the PRDM9A binding-site dataset could have occurred by chance alone, had to be 
rejected (empirical p < 0.00001; Supp. Text S1). Instead, the simulations imply a non-random 
overlap between the PRDM9A binding-site dataset and the SERs of type-1 NF1 deletions (Supp. 
Figure S9; Figure 3). 
Co-location of SERs, GQs and regions flanking PRDM9A binding-sites in PRS2 
The co-location of GQs, the PRDM9A binding site data set and SERs was observed significantly 
more often in PRS2 than elsewhere in the region of high sequence homology between NF1-REPa 
and NF1-REPc including also PRS1 (two-tailed p = 0.0005; Fisher's exact test) (Supp. Table 
S15). This finding implies that the co-location of GQs and PRDM9A binding sites within PRS2 
makes a significant contribution to the increased NAHR frequency within this hotspot. 
Overlap between other NAHR-mediated deletion breakpoints and GQs or PRDM9A 
binding-sites  
By means of comparable simulation analyses to those described above, we investigated whether 
the SERs of other NAHR-mediated deletions such as those associated with hereditary neuropathy 
with liability to pressure palsies (HNPP) would also overlap in a non-random fashion with GQs 
or regions harbouring PRDM9A binding-sites (Supp. Figures S10 and S11). We selected these 
SERs for analysis since they have been very precisely mapped (Turner et al., 2008). A non-
random overlap was indeed noted between SERs of CMT1A-REP-mediated rearrangements and 
GQs as well as regions flanking PRDM9A binding-sites (empirical p < 0.00001; Supp. Figures 
S10 and S11).  
 
Discussion 
Type-1 NF1 deletions are the most common among all types of large NF1 deletion (Messiaen et 
al., 2011). Hence, their characterization is important not only in the context of the determination 
of the deletion-causing mutational mechanisms but also in relation to the genotype/phenotype 
relationship in patients with large NF1 deletions. In the study presented here, we analysed 236 
type-1 NF1 deletions, initially identified by MLPA, in order to determine the precise proportion 
of type-1 deletions with breakpoints located within the known NAHR hotspots PRS1 and PRS2. 
One further aim of our study was to determine the proportion of type-1 NF1 deletions not 
mediated by NAHR but instead by other mutational mechanisms. Our study has not been biased 
in that we did not omit any deletions from further consideration when their breakpoints could not 
be narrowed down to specific genomic regions. Instead, all 236 deletions were analysed at the 
highest possible resolution. Taken together, the breakpoints of 234 (99.2%) of the 236 type-1 
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deletions investigated were mediated by NAHR. Only two deletions exhibited breakpoints that 
were not located within regions of high sequence homology between NF1-REPa and NF1-REPc 
and hence were most unlikely to have been mediated by NAHR (Figure 1, Supp. Figures S6 and 
S7). We conclude that NAHR is the preponderant mutational mechanism causing type-1 NF1 
deletions. Previous analyses have indicated that the majority of type-1 NF1 deletions are of 
maternal origin and caused by an interchromosomal exchange during meiosis I (López-Correa et 
al., 2000; Neuhäusler et al., 2018). Taken together with the data presented here, we may infer that 
NAHR during meiosis is the predominant mechanism underlying type-1 NF1 deletions.  
Our analysis demonstrates a pronounced clustering of breakpoints within the known NAHR 
hotspot PRS2; although this has been suggested by the authors of previous studies, these were not 
performed systematically enough to allow the determination of the precise proportion of PRS2-
mediated deletions among an unselected group of type-1 NF1 deletions (De Raedt et al., 2006; 
Hillmer et al., 2016). Here, we demonstrate that 179 of 236 deletion breakpoints (75.8%) were 
located within PRS2 whereas 39 (16.5%) were located within PRS1, which therefore represents a 
much weaker NAHR hotspot than PRS2. Only 18 deletions (7.6%) exhibited breakpoints that 
were not located within these known NAHR hotspots. The breakpoints of 16 of these 18 deletions 
were either located within the 14-kb region of high sequence homology between the NAHR 
hotspots PRS1 and PRS2 (N=13) or centromeric to PRS1 but still within the region of high 
sequence similarity between NF1-REPa and NF1-REPc (N=3) (Figure 2). These 16 deletions 
were all mediated by NAHR. Remarkably, eight of these deletions exhibited breakpoints located 
within a short 476-bp region located between PRS1 and PRS2, which may represent another 
preferred region of DNA double strand breaks within NF1-REPa and NF1-REPc (Supp. Figure 
S1, Figure 2).  
The clustering of type-1 NF1 deletions is remarkable and suggests that specific sequence features 
are causally responsible for it. A high GC-content has been identified in the PRS2 hotspot and 
also in PRS1, although less pronounced than in PRS2 (Hillmer et al., 2016). A high GC-content 
has also been noted in other genomic regions harbouring NAHR breakpoints (Dittwald et al., 
2013). Further, allelic homologous recombination (AHR) hotspots active during meiosis have 
also been shown to be characterized by a high GC-content (Gerton et al., 2000; Fullerton et al., 
2001; Bagshaw et al., 2006; Hansen et al., 2011). Genomic regions rich in GC may harbour G-
quadruplex forming DNA sequences (GQs) which have the capacity to adopt non-B DNA 
conformations and cause chromosome breakage in vivo (reviewed by Bochman et al., 2012; van 
Kregten and Tijsterman, 2014). Failure to resolve non-canonical DNA structures such as G-
quadruplexes has been associated with genomic instability (Kruisselbrink et al., 2008; Ribeyre et 
al., 2009; Mac Donald et al., 2016; reviewed by Rhodes and Lipps; Wanzek et al., 2017).  
GQs have been suggested to promote meiotic homologous recombination since genome-wide 
computational studies in yeast demonstrated the co-location of GQs and meiotic double strand 
breaks (Capra et al., 2010). A role for GQs during meiotic AHR is also supported by the finding 
that Hop1, a protein that is critical for the synapsis of homologous chromosomes during meiosis, 
binds to G-quadruplex forming DNA sequence structures in vitro (Muniyappa et al., 2000; 
Anuradha and Muniyappa, 2004). Hop1 promotes intermolecular pairing between GQs at sites of 
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meiosis-specific DNA double strand breaks suggesting that GQs could mediate the pairing 
between homologous chromosomes during meiotic prophase I (Kshirsagar et al., 2017). Since 
meiotic AHR and NAHR events are assumed to be mechanistically similar processes (Lupski et 
al., 2004; Liu et al., 2011), GQs are likely to play an important role during NAHR as well as 
AHR. This postulate is corroborated by our observation of the co-location of GQs and 
breakpoints (strand exchange regions, SERs) of type-1 NF1 deletions (Supp. Figure S8; Figure 
3). A comparable co-location of SERs and GQs was also observed for NAHR-mediated 
rearrangements between the CMT1A-REPs at 17p12 causing CMT1A or HNPP (Supp. Figure 
S10). These findings may be indicative of a general causal relationship between GQs and NAHR 
breakpoints which may extend beyond type-1 NF1 deletions so as to include other NAHR 
breakpoints at other loci.  
In many species including human, the DNA-binding histone methyltransferase PRDM9 has been 
shown to be an important regulator of AHR during meiosis. PRDM9 determines the location of 
recombination hotspots and facilitates the association of hotspots with the chromosome axis at 
sites of programmed DNA double-strand breaks (DSBs) thereby initiating the genetic exchange 
between chromosomes (reviewed by Paigen and Petkov, 2019). In addition to regulating AHR 
activity at hotspots, PRDM9 is also likely to be an important regulator of NAHR activity (Berg et 
al., 2010; Pratto et al., 2014). In the current study, a significant co-location of regions flanking 
PRDM9A binding-sites and the SERs of type-1 NF1 deletions (Supp. Figure S9). We also 
observed a significant co-location  of regions flanking PRDM9A binding-sites and the SERs of 
deletions mediated by the CMT1A-REPs at 17p12 (Supp. Figure S11). These findings thus 
appear to be generalizable, and as with GQs, PRDM9A binding-sites constitute important 
sequence features that not only contribute to determining the location of NAHR-mediated 
breakpoints but which may also be responsible for the clustering of these breakpoints. The 
significant co-location of GQs and PRDM9A binding-sites within PRS2 further implies that these 
elements may functionally synergize so as to promote the greatly increased NAHR activity within 
this hotspot.  
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Figure legends: 
 
Figure 1: Breakpoint-analysis in 236 type-1 NF1 deletions initially identified by MLPA. The 
breakpoints of 84 of these 236 deletions were characterized in previous studies by means of four 
classical breakpoint-spanning PCRs (BS-PCRs) which detect breakpoints located within the 
NAHR hotspots PRS1 and PRS2. In the present study, we analysed 152 additional type-1 NF1 
deletions in this cohort. Taken together, 201 type-1 NF1 deletions were initially found to be 
positive for the classical BS-PCRs whereas the breakpoints of 35 deletions could not be identified 
by these means. To identify the breakpoints of these 35 remaining deletions, we improved the 
PCR conditions for the classical BS-PCR, established new BS-PCRs, and performed both 
custom-designed array CGH and paralog-specific PCRs (PS-PCRs) to determine the copy 
number of the corresponding genomic regions [HILDE: Is this correct? I am trying to avoid using 
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the word ‘performed’ twice in the same sentence]. The locations of the breakpoints are indicated 
in round brackets whereas the relative proportions are given in square brackets. Taken together, 
234 of the 236 type-1 NF1 deletions analysed were found to be mediated by NAHR, whereas 
only two deletions had breakpoints located within regions that were not homologous between 
NF1-REPa and NF1-REPc (Supp. Figures S5 and S6) and hence were not mediated by NAHR.  
 
Figure 2: Schema of the low-copy repeats NF1-REPa and NF1-REPc and locations of the type-1 
NF1 deletion breakpoints analysed. (A) Structure of NF1-REPa and NF1-REPc. The LCRs 
exhibit a modular structure comprising different segmental duplications. H19 indicates the 
regions with high sequence similarity to chromosome 19p13.12. The 51-kb directly oriented 
region of high sequence homology between NF1-REPa and NF1-REPc is indicated by white 
horizontal arrows. (B) Summary of the breakpoint location of 234 NAHR-mediated type-1 
deletions pertaining to NF1-REPa. (C) Locations of the breakpoints of the 13 deletions which 
exhibited strand exchange regions (SERs) between PRS1 and PRS2. The SER of the deletion in 
patient R608111/100 could not be identified at the highest possible resolution owing to the lack 
of DNA. However, paralog-specific PCRs indicated that the breakpoints were located between 
PRS1 and PRS2 within a 6-kb region homologous between NF1-REPa and NF1-REPc. Five 
patients exhibited breakpoints at the centromeric end of PRS2, thereby necessitating an increase 
in our estimation of the length of PRS2.   
 
Figure 3: Locations of the 129 SERs of type-1 NF1 deletions, 21 G-quadruplex forming 
sequences and 26 PRDM9A binding sites within the 51-kb region of high sequence homology 
between NF1-REPa and NF1-REPc (marked by the grey rectangle). The most common variant of 
the human PRDM9 protein (termed PRDM9A) recognizes the consensus sequence 5′-
CCNCCNTNNCCNC-3′. These predicted PRDM9A consensus binding sites are indicated by 
green dots. PRDM9A also binds to variants of this consensus motif and these variant binding sites 
(5'-CCNCCNCNNCCNC-3' and 5'-CCNCCNCNNCANC-3') are indicated by lilac dots. The 
relative locations of the NAHR hotspots PRS1 and PRS2 are also indicated. A non-random 
overlap of SERs and G-quadruplex forming sequences, and between SERs and 250-bp regions 
flanking PRDM9A binding sites, was observed. 
 
 
